Prof. Carl Wittwer
Inbiome, developing a new PCR technology capable of simultaneous identification of hundreds of bacterial pathogens in a single test, welcomes Professor Dr. Carl Wittwer to its Advisory Board
20. September 2024 05:03 ET | inbiome
Amsterdam, The Netherlands, September 20, 2024. Inbiome, a pioneer in advanced molecular diagnostics, today announced the appointment of Professor Dr. Carl Wittwer (picture), a global authority in PCR...
Global Food Diagnostic Market
Food Diagnostics Market Surges to USD 23.5 Billion by 2028 Driven by Safety and Quality Testing
22. Januar 2024 12:28 ET | Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Food Diagnostics Market by Type (Systems, Test Kits, and Consumables), Testing Type (Safety and Quality), Site (Outsourcing Facility and Inhouse), Food...
new_logo.png
Infectious Disease Diagnostics Market to reach USD 40 billion by 2032, Says Graphical Research Powered by GMI
05. Juni 2023 04:00 ET | Graphical Research
Selbyville, Delaware, June 05, 2023 (GLOBE NEWSWIRE) -- Infectious Disease Diagnostics Market size will be worth USD 40 billion by 2032. The growing prevalence of infectious diseases across the...
22157.jpg
Global Food Pathogen Detection Technology Market Report 2022 - Featuring SGS SA, Bureau Veritas and Intertek Among Others
14. April 2022 06:43 ET | Research and Markets
Dublin, April 14, 2022 (GLOBE NEWSWIRE) -- The "Food Pathogen Detection Technology Global Market Report 2022: By Technology, By Food, By Type" report has been added to ResearchAndMarkets.com's...
22157.jpg
Global End-to-end Food Traceability and Safety Market Report 2022: Analyzing Technology Advancements that Improved Food Contaminant Tracking and Detection
04. April 2022 06:33 ET | Research and Markets
Dublin, April 04, 2022 (GLOBE NEWSWIRE) -- The "Smart Electronics and Spectral Imaging to Transform End-to-end Food Traceability and Safety" report has been added to ResearchAndMarkets.com's...
22157.jpg
United States Biodefense-Related Rapid Pathogen Identification and Treatments Markets Outlook Report: Data from 2019-2020, estimates for 2021 and CAGR projections to 2026
12. November 2021 05:13 ET | Research and Markets
Dublin, Nov. 12, 2021 (GLOBE NEWSWIRE) -- The "The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments 2021-2026" report has been added to ResearchAndMarkets.com's...
NEPH logo.png
Nephros to Present at the Q1 Virtual Investor Summit
16. März 2021 07:45 ET | Nephros, Inc.
SOUTH ORANGE, N.J., March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to...
LexaGene LOGO.png
Testing’s Critical Role in Stemming the Tide
22. Juli 2020 08:30 ET | LexaGene Holdings Inc.
NEW YORK, July 22, 2020 (GLOBE NEWSWIRE) -- via NetworkWire — LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"),...
Diomics.png
Update: Diomics Corp. Announces Development of Intellectual Property and Patents Related to the Identification of Airborne Pathogens
05. Februar 2020 08:22 ET | Diomics Corporation
DiomatTM Technology Can Identify Deadly Airborne Pathogens and be Deployed in Fixed Structures Such as Aircraft, Buildings, Train Systems and the Like  SAN DIEGO, CA, Feb. 05, 2020 (GLOBE...
PositiveID Subsidiar
PositiveID Subsidiary Chief Science Officer Joins Cambridge Healthtech Institute’s 26th Biodetection Technologies: Biothreat and Pathogen Detection
25. Juni 2018 08:00 ET | PositiveID Corporation
DELRAY BEACH, Fla., June 25, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSID) announced today its ExcitePCR subsidiary has joined Cambridge Healthtech...